These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 21267262)

  • 1. Hemoccult II Screening for Bowel Cancer: Will Family Practice Patients Accept It?
    Sangster JF; Gerace TM; Bass MJ
    Can Fam Physician; 1986 Feb; 32():289-95. PubMed ID: 21267262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the specificity and sensitivity of Hemoccult and HemoQuant in screening for colorectal neoplasia.
    St John DJ; Young GP; McHutchison JG; Deacon MC; Alexeyeff MA
    Ann Intern Med; 1992 Sep; 117(5):376-82. PubMed ID: 1503328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acceptability of the Hemoccult test in general medical practice. Results of a pilot study].
    Archambault F; Durand G; Faivre J; Voilquin JP; Archambault P; Riou F; Ageorges P; Archambault ML; Delville JM; Fesneau M
    Bull Cancer; 1989; 76(10):1071-5. PubMed ID: 2699722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceptability of a faecal occult blood screening protocol for carcinoma of the colon in family practice.
    Sangster JF; Gerace TM; Bass MJ
    Fam Pract; 1986 Dec; 3(4):246-50. PubMed ID: 3803770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Routine hemoccult screening: the current evidence.
    Frank JW
    Can Fam Physician; 1985 Jan; 31():99-103. PubMed ID: 21279149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for colorectal cancer. A comparison of 3 fecal occult blood tests.
    Levin B; Hess K; Johnson C
    Arch Intern Med; 1997 May; 157(9):970-6. PubMed ID: 9140267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ontario Maternal Serum Screening Program: practices, knowledge and opinions of health care providers.
    Carroll JC; Reid AJ; Woodward CA; Permaul-Woods JA; Domb S; Ryan G; Arbitman S; Fallis B; Kilthei J
    CMAJ; 1997 Mar; 156(6):775-84. PubMed ID: 9084382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychological Barriers and Facilitators of Colorectal Cancer Screening: A French Qualitative Study.
    Bridou M; Aguerre C; Gimenes G; Kubiszewski V; Le Gall A; Potard C; Sorel O; Reveillere C
    Health Psychol Res; 2013 Apr; 1(2):e22. PubMed ID: 26973907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemoccult screening in detecting colorectal neoplasm: sensitivity, specificity, and predictive value. Long-term follow-up in a large group practice setting.
    Allison JE; Feldman R; Tekawa IS
    Ann Intern Med; 1990 Mar; 112(5):328-33. PubMed ID: 2407166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Bayesian approach to toxicological testing.
    Felli JC; Leishman DJ
    J Pharmacol Toxicol Methods; 2020 Sep; 105():106898. PubMed ID: 32735877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceptability and compliance in screening for colorectal cancer with fecal occult blood test.
    Adamsen S; Kronborg O
    Scand J Gastroenterol; 1984 Jun; 19(4):531-4. PubMed ID: 6463577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comparison of Fecal Immunochemical and High-Sensitivity Guaiac Tests for Colorectal Cancer Screening.
    Shapiro JA; Bobo JK; Church TR; Rex DK; Chovnick G; Thompson TD; Zauber AG; Lieberman D; Levin TR; Joseph DA; Nadel MR
    Am J Gastroenterol; 2017 Nov; 112(11):1728-1735. PubMed ID: 29016558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Compliance rate of screening colonoscopy and its associated factors among high-risk populations of colorectal cancer in urban China].
    Chen HD; Li N; Ren JS; Shi JF; Zhang YM; Zou SM; Zheng ZX; Zhang K; Dai M
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Mar; 52(3):231-237. PubMed ID: 29973000
    [No Abstract]   [Full Text] [Related]  

  • 14. Patients' experience of screening CT colonography with reduced and full bowel preparation in a randomised trial.
    Sali L; Ventura L; Grazzini G; Borgheresi A; Delsanto S; Falchini M; Mallardi B; Mantellini P; Milani S; Pallanti S; Zappa M; Mascalchi M
    Eur Radiol; 2019 May; 29(5):2457-2464. PubMed ID: 30402705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of fecal occult-blood tests for colorectal-cancer screening.
    Allison JE; Tekawa IS; Ransom LJ; Adrain AL
    N Engl J Med; 1996 Jan; 334(3):155-9. PubMed ID: 8531970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Views of a general population on mass screening for colorectal cancer: the Burgundy Study.
    Arveux P; Durand G; Milan C; Bedenne L; Lévy D; Doan BD; Faivre J
    Prev Med; 1992 Sep; 21(5):574-81. PubMed ID: 1438107
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.